How to Navigate the Fast Track Landscape
Across Europe, authorities are examining ways to make new drugs—in particular orphan drugs—available to patients more quickly while maintaining the highest standards for drug approval.
As part of Sidley’s Eye on Bio series, we invite you to join us for a roundtable with Dr. Richard Barker, co-author of the UK Accelerated Access Review and Dr. Stefan Blesse, a recognized expert in EMA marketing authorization procedures, to explore the fast track pathways available today and expected in the future.
The panel will be moderated by Maarten Meulenbelt, a regulatory litigation partner in Sidley’s EU Life Sciences practice.
Registration and Breakfast
9:30 a.m. – 11:00 a.m.
For any queries, please contact:
+44 20 7360 3645
This event is open to individuals active in the pharma and biotech sectors and the investment community.